BridgeMD
Prevention study for Chemotherapy Induced Peripheral Neuropathy (CIPN)
Official title The Effect of Personalized Exercise Interventions for the Prevention of Chemotherapy-induced Peripheral Neuropathy
ClinicalTrials.gov ID: NCT06962579
What this study is testing
- What it's testing
- Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and common side effect of neurotoxic cancer treatment. The most frequent symptoms include sensory disturbances and weakness in the hands and/or feet.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- age above 18 years
- a primary diagnosis of breast, gynaecological or colon cancer, without distant metastasis
- been chemotherapy naïve
- been scheduled for at least 12 weeks of taxane- or platinum-based chemotherapy without other neurotoxic chemotherapy
You likely can't join if
- life expectancy of less than six months according to the patient's oncologist or designee
- advanced stage of disease
- having a known current neuropathy
- having cognitive or physical limitations that contraindicate participation in a low- to moderate intensity home-based walking and progressive...
- not able to read and understand Dutch
- not able to provide informed consent
See the full eligibility criteria
- age above 18 years
- a primary diagnosis of breast, gynaecological or colon cancer, without distant metastasis
- been chemotherapy naïve
- been scheduled for at least 12 weeks of taxane- or platinum-based chemotherapy without other neurotoxic chemotherapy
- life expectancy of less than six months according to the patient's oncologist or designee
- advanced stage of disease
- having a known current neuropathy
- having cognitive or physical limitations that contraindicate participation in a low- to moderate intensity home-based walking and progressive resistance program (determined by the patient's oncologist)
- not able to read and understand Dutch
- not able to provide informed consent
- not able to participate during the entire study period
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Edegem, Belgium
- Leuven, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edegem, Belgium; Leuven, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.